Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
2.450
+0.030 (1.24%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Harvard Bioscience Revenue

Harvard Bioscience had revenue of $23.10M in the quarter ending June 30, 2024, a decrease of -19.69%. This brings the company's revenue in the last twelve months to $101.13M, down -11.36% year-over-year. In the year 2023, Harvard Bioscience had annual revenue of $112.25M, down -0.96%.

Revenue (ttm)
$101.13M
Revenue Growth
-11.36%
P/S Ratio
1.04
Revenue / Employee
$243,089
Employees
416
Market Cap
106.85M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023112.25M-1.09M-0.96%
Dec 31, 2022113.34M-5.57M-4.68%
Dec 31, 2021118.90M16.80M16.46%
Dec 31, 2020102.10M-14.08M-12.12%
Dec 31, 2019116.18M-4.60M-3.81%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Assertio Holdings 132.19M
OptimizeRx 83.20M
EDAP TMS 66.48M
Assembly Biosciences 21.48M
CervoMed 9.65M
Cue Biopharma 8.30M
Cibus 2.96M
Quantum-Si incorporated 1.70M
Revenue Rankings